You can read the full article at Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese rats The drug tesofensine, which blocks the reuptake of dopamine, serotonin, and norepinephrine, has shown promise as a treatment for obesity
FIGURE 2 In 1976 Benson and Talalay discovered that the cytosolic fraction of rat liver catalyzes the same steroid isomerization of 5-androsten-3,17-dione, but in distinction from the bacterial enzyme the reaction included reduced glutathione as a designated coenzyme ( 1 mg 1 ) in comparison with the five orders of magnitude higher activity of the Pseudomonas enzyme ( In retrospect, it is clear that the ketosteroid isomerase activity of the GST in human liver ( 1 B 1 and B 1 B 2 in Mechanism of Ketosteroid Isomerase Catalyzed by Mammalian Glutathione Transferases The double-bond isomerization of ketosteroids has been investigated with 5-AD and 5-PD (Figure 2)
10.1016/j.jneuroim.2008.12.002 92 LiY.YaoJ.HanC.YangJ.ChaudhryM.WangS.et al (2016)
The first publications reported enzyme activity involving displacement of a halide ion from an aromatic compound, resulting in an S-substituted glutathione conjugate ( GSTs were first recognized as enzymes inactivating xenobiotics, in particular electrophilic mutagens and carcinogens, leading to their excretion as mercapturic acids ( An independent set of reports identified a remarkably abundant protein in liver with affinity for carcinogens, steroid hormones, bilirubin and synthetic dyes
_1772706284.jpg)